Background: Breast cancer (BC) is an important issue both in medicine and public health as it is the leading malignancy with high incidence and mortality among women worldwide. The objective of this research was to determine the associations of BC with oral contraceptive (OC) use among Thai premenopausal women (TPW). Materials and Methods: A case-control study was conducted among TPW attending the National Cancer Institute, with 257 cases and 257 controls in 2013-2014. Cases and controls were matched by age (± 5 years), residential area and duration of attendance. Data were collected with a questionnaire that comprised 2 sections: part 1 socio-demographic characteristics, and part 2 health risk behavior and reproductive factors. The obtained data were analyzed using descriptive and analytic statistics with a computerized statistical package. Results: The study participants were mainly 40-44 years old (60 %) with an average age of 39 years. The major BC type was invasive ductal carcinoma (91.8%). Multiple unconditional logistic regression analysis, controlling for possible confounding factors, revealed that TPW with OC use increased the risk of BC by a factor of over 3 times (ORadj=3.39, 95%CI =1.99-5.75). In addition, the greater the duration of OC, the greater the risk (ORadj 6-10 yrs=3.91, 95%CI = 1.99-7.64, ORadj >10 yrs=4.23, 95%CI = 2.05-8.71). Conclusions: From our findings, a surveillance system of cancer risk with OC use should be conducted, accompanied by an exercise promotion campaign among risk groups, providing information and counseling for physical exercise and physical activities, weight control and basic adjustment for a healthy lifestyle to reduce BC. The present study was carried out to assess the association between OC use and BC occurrence among TPW.
Introduction
Cancers are the top leading cause of death. According to estimates of The World Health Organization (WHO), approximately 8.2 million cancer deaths occurred in 2014 and mortality mainly occurred in developing countries. Of these, 3.4 million are male and female 3.3 million. Almost 70 % of all cancers was seen in underdeveloped and developing countries (Siegel et al., 2015) . At present, it is well established that BC is the most commonly diagnosed invasive cancer and the leading cause of cancer death among women worldwide including in Thailand (Siegel et al., 2015; National Cancer Control Committee, 2013; Bureau of Policy and Strategies, 2011; Bureau of Policy and Strategies, 2015) . Causes of being BC are likely to be multifactorial. Some studies found that OC use is one of the risk factors of BC (Soroush et al., 2016; Rosenberg et al., 2009) . The association between OC use and BC risk has been examined in numerous studies, mainly in western countries. In Thailand, there are quite very few studies of this association among premenopausal women. exposure in cases = 0.68 (Umpan, 2004) ; Zα/2 = 1.96 at α = 0.05; Zβ = 0.84 at β = 0.20; and P = 0.5. The calculated sample size in each group was at least 256.
Tool and Measurements
Data collection was obtained by interviewing the study subjects by researcher and trained research assistants. The questionnaire comprised socio-demographic factors, health risk behaviors, reproductive factors, obesity and cancer status. While BC information was collected by laboratory and pathological results, namely, TNM classification, stage of disease, hormone receptor test, and date of diagnosis with BC.
Variable definitions
Premenopausal women were defined as those still having menstrual cycles at the time of study.
Ethical Considerations
The study was reviewed and approved by the Ethics Committee for research of National Cancer Institute, Ministry of Public Health (148/2556) and the Ethics Committee for Research in Human Subjects of the Faculty of Public Health, Mahidol University (Ref No. MuPH 2014-090) and agreed with the Helsinki declaration. All participants participated in this study are on a voluntary basis. Informed consent to participate in the study was obtained from participants after providing sufficient information. Information was collected by a self-administered questionnaire with the help and supervision of research assistants. Confidentiality was well kept throughout the study using anonymous technique (respondents were identified by code numbers to ensure confidentiality and the results were analyzed as a whole).
Statistical Analyses
The data were analyzed with SPSS version 18 (IBM, NY, USA). Categorical variables were given as a frequency and percentage, crude odds ratio, 95 % Confidence Interval (CI) of OR and p-value. The numerical variables were expressed as mean, minimum and maximum, and standard deviation (SD). Univariate analysis was performed using the chi-square test to differentiate proportional exposures between BC patents and controls for categorical variables. Adjusted odds ratio and the 95 % CI of OR were calculated from multiple unconditional logistic regression to examine associations between BC occurrence and BMI, adjusted for potential confounding factors of reproductive factors and health risk behaviors. A p-value of < 0.05 was considered to be statistically significant.
Results

Demographic Characteristics of Cases and Controls
A total of 514 TPW participated in the case-control study (1:1). The average age of subjects was 39 years. Table 3 .
BC Patients' Characteristics
Cases were newly patients with BC diagnosed by pathological confirmation and laboratory testing during November 2013-December 2014. Majority of them were 55-64 kg (40.5%) and 150-159 cm (65.7%). Focusing on body size, 60.7% showed obesity and overweight. Location of BC, mostly in both sides (52.2%). Most of study cases were IDC-NOS (91.8%), stage II (45.5%). For OC use group, duration for OC use, mostly 6-10 yr. (41.9%).
Discussion
Study participants were the TPW, mostly aged 40-44 years (60%). Socio-demographic characteristics of cases and controls were quite alike. When controlled by health risk behaviors and reproductive factors, found that TPW with OC use was being BC risks. Our findings indicated that women with OC use were about 3 times risk to develop BC. It was consistent with the previous studies (Soroush et al., 2016; Rosenberg et al., 2009; Nyante et al., 2008; Kahlenborn et al., 2006; Newcomer et al., 2003; Hemminki et al., 2002; Grabrick et al., 2000) , meanwhile some studies showed the contrary results (Haile et al., 2006; Silvera et al., 2005; Mine et al., 2005; Jernstrom et al., 2005; Tessaro et al., 2001; Van Hoften et al., 2000) .
The reason to support the association owing to estrogen hormone in OC pills, therefore it will have a cohesion with specific receptor on cancer cell's surface and then it will send the biochemical signals and activate cell multiplication (Howlader et al., 2016) . The association had no evidence in OC use with only progesterone (McNaught et al., 2006) . In addition, the present studies revealed the risk of BC had increased according to duration of OC use and it's consistent with some studies (Howlader et al., 2016; Collaborative Group on Hormonal Factors in Breast Cancer, 1996) . Therefore, birth control with BC patients should be namely, contraceptive pills with progesterone, depot medroxyprogesterone acetate injection, intrauterine device (IUD) with progesterone, and so on (Kabos and Borges, 2011) . In addition, breast self examination is very necessary, so women should be done correctly (Smith et al., 2003) . For women ≥ 40 years should be checked up with mammogram annually (Smith et al., 2003; American College of Radiology, 2013) . There are a lot of tools for BC risk evaluation, such as the Gail Model, the Claus Model, the Tyree-Cuzick Model and the BRCAPRO model (Santen et al., 2007; Hollingsworth et al., 2004) . For Thais, campaign of women aged ≥ 20 years to examine by themselves, they should be aware of advantages and limitations of this technique, support breast feeding after give birth 6 months, reduce alcohol consumption and reduce obesity (National Cancer Control Committee, 2013) . Therefore, the surveillance of cancer risk and contraceptive use is the crucial measure to reduce BC risks.
Advantages and limitation of the Study
There are some advantages of this case-control study. First, the National Cancer Institute is the specialized hospital for cancer patients. Second, they are easily identified, and provide sufficient numbers. Finally, cases are newly BC patients diagnosed and confirmed by pathologists, which lead to the reduction in classification bias. Some limitations of this study should be noted. First, the study was a hospital based case-control study, therefore, the representative of target population couldn't be mentioned. Second, it was very difficult to select the suitable controls. However, we matched cases and controls by age, residence and duration of attending. In summary, it should be the surveillance system of cancer risks and OC use and campaign of cancer prevention such as proper exercise, healthy diet, weight control and basic methods for health lifestyle among risk groups (National Cancer Control Committee, 2013) , it will minimize and reduce risks of developing BC. 
